The multifunctional membrane glycoprotein CD36 is expressed in different types of cells and
plays a key regulatory role in cellular lipid metabolism, especially in cardiac muscle. CD36 …

Prostate cancer is the most prevalent type of cancer in senior American men. Currently, the
five-year survival rate after the initial diagnosis of prostate cancer is close to 100 …

Cancer stem cells (CSCs) are a subset of cancer cells with self-renewal ability and tumor
initiating properties. Unlike the other non-stem cancer cells, CSCs resist traditional therapy …

The membrane protein CD36 is a lipid transporter, scavenger receptor, and receptor for the
antiangiogenic protein thrombospondin 1 (TSP1). CD36 is expressed by cancer cells and by …

The challenge of drug resistance in intrahepatic cholangiocarcinoma (ICC) is intricately
linked with lipid metabolism reprogramming. The hepatic lipase (HL) and the membrane …

Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to low-density lipoprotein (LDL)
receptor and fatty acid translocase CD36, inducing lysosomal degradation of these two …

CD36 is a scavenger receptor that has been reported to function as a signaling receptor that
responds to pathogen-associated molecular patterns (PAMPs) and damage-associated …

CD36 expression in both immune and non-immune cells is known to be directly involved in
cancer metastasis. Extracellular vesicles (EVs) secreted by malignant melanocytes play a …

Background: Novel agents targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)
effectively reduce the concentration of low-density lipoproteins. These agents mediating …